Glaxo Smith Kline (BIOC.CA) Disclosure Form For The BoD & The Shareholders' Structure
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 30/06/2020 according to Article 30 of the Listing Rules.
the Disclosure Form (1,365 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 30/06/2020 according to Article 30 of the Listing Rules.
the Disclosure Form (1,365 KB)
Comments